1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine

Term ID

CHEBI:17476

Synonyms

1-alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine
1-alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamines
1-Alkenyl-2-acylglycerophosphoethanolamine
1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphoethanolamine
2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphoethanolamine
Ethanolamineplasmalogen
O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine
Phosphatidalethanolamine
Plasmenylethanolamine

(all 9)

Definition

A glycerophosphoethanolamine compound having an alk-1-enyl substituent at the 1-position and an acyl substituent at the 2-position.

References

KEGG:C04756

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycerophosphoethanolamine olefinic phospholipid

glycerophosphoethanolamine olefinic phospholipid Show first 5 Terms
has subtype: 1-(1Z,9Z-octadecadienyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z,11Z-octadecadienyl)-2-linoleoyl-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-(8Z,11Z,14Z-icosatrienoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine ... Show All 40 Terms

1-(1Z,9Z-octadecadienyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z,11Z-octadecadienyl)-2-linoleoyl-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-(8Z,11Z,14Z-icosatrienoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphoethanolamine 1-(1Z-hexadecenyl)-2-oleoyl-sn-glycero-3-phosphoethanolamine 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-octadecenyl)-2-(8Z,11Z,14Z-icosatrienoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine 1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine 1-(1Z-octadecenyl)-2-hexadecanoyl-sn-glycero-3-phosphoethanolamine 1-(1Z-octadecenyl)-2-linoleoyl-sn-glycero-3-phosphoethanolamine 1-(hexadec-1-enyl)-2-hexadecanoyl-sn-glycero-3-phosphoethanolamine 1-[(1Z,11Z)-octadecadienyl]-2-oleoyl-sn-glycero-3-phosphoethanolamine 1-[(1Z,11Z)-octadecadienyl]-2-palmitoyl-sn-glycero-3-phosphoethanolamine 1-O-(hexadec-1-enyl)-2-O-octadeca-9,12-dienoyl-sn-glycero-3-phosphoethanolamine 1-octadecadienyl-2-icosatetraenoyl-sn-glycero-3-phosphoethanolamine PE(18:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) PE(P-16:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) PE(P-18:0/15:0) PE(P-18:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) PE(P-18:1(9Z)/15:0) phosphatidylethanolamine P-20:0 phosphatidylethanolamine P-32:1 phosphatidylethanolamine P-34:1 phosphatidylethanolamine P-34:2 phosphatidylethanolamine P-34:3 phosphatidylethanolamine P-36:1 phosphatidylethanolamine P-36:2 phosphatidylethanolamine P-36:5 phosphatidylethanolamine P-38:1 phosphatidylethanolamine P-38:2 phosphatidylethanolamine P-38:3 phosphatidylethanolamine P-38:4 phosphatidylethanolamine P-38:6 phosphatidylethanolamine P-40:4 phosphatidylethanolamine P-40:6 phosphatidylethanolamine P-40:7 Show first 5 Terms
inverse is_tautomer_of: 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion

1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion Show first 5 Terms
is_tautomer_of: 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion

1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion Show first 5 Terms

Phenotype

Phenotype resulting from 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine

Phenotype where environments contain 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine

Phenotype modified by environments containing 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine

Phenotype affecting 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine

Human Disease Model